Skip to main content
. 2020 Sep 30;12(10):628. doi: 10.3390/toxins12100628

Table 3.

Advantages and disadvantages of in vivo and in vitro models in the evaluation of bioavailability.

Models Advantages Disadvantages
In vitro models
Simulation of gastrointestinal transformation Similar to the physiological processes in the human body
Suitable for high-throughput format
Ability of testing a specific mechanisms of action
Focus on small number of components
Validation with reference material
No hormonal and nervous control
Lack of feedback mechanisms
Absence of mucosal cell activity
Deficiency of complexity of peristaltic movements, and involvement of the local immune system
Homeostatic mechanisms are not present
Difficult to achieve the anaerobic assay conditions
Caco-2 cells Reproducibility of results
Provides information about efficiency of digestion, absorption
Ability of studying transport mechanisms
Phenotypically similar to absorptive epithelial cells
Suitable for high-throughput format
Human colonic adenocarcinoma origin
Higher TEER value than human intestine
Lack of mucin, microflora, biofilms, and epithelial cell types
Variation of efflux transporters expression levels
Incapability of simulating the changes of pH
In vivo models In vivo condition
Well-known biology
Selection of specific subjects
Better-understanding kinetic of mycotoxins
High-throughput limitation
Extremely complex functional systems
Influence of different factors-phenotypic variation
Lack of certified reference standards
Ethical issues and high cost
Time consuming and labor intensive

TEER: Transepithelial electrical resistance.